Test Price
2,800 AED✅ Home Collection Available
COL2A1 Gene Czech Dysplasia Genetic Test in Dubai
Executive Summary & Core Metrics
- Diagnostic Sensitivity: 99.9% via ISO 15189 accredited next‑generation sequencing processing.
- VIP Mobile Phlebotomy & Cold‑Chain Home Collection: ISO‑certified temperature‑controlled sample pick‑up available daily from 8 AM to 11 PM.
- Telephonic Post‑Test Clinical Guidance: Comprehensive result interpretation by a consultant medical geneticist.
- Insurance Verification: Direct billing eligibility check via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The COL2A1 NGS test analyzes the entire coding region of the COL2A1 gene using next‑generation sequencing to detect mutations responsible for Czech dysplasia, a rare autosomal dominant spondyloepiphyseal dysplasia. This highly accurate test aids in definitive diagnosis, family screening, and personalized management strategies.
| Feature | Our Test (NGS) | Closest Alternative (Targeted Sequencing) |
|---|---|---|
| Methodology | Full‑gene NGS with CNV detection | Sanger sequencing of select exons |
| Diagnostic Sensitivity | >99.9% | ~95% (depends on coverage) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Price | 2,800 AED | ~3,500 AED |
Physician Insight & Safety Protocols
"Genetic testing must be interpreted alongside family history and clinical evaluation. A negative result does not exclude all related disorders, and a positive result requires careful genetic counseling. This test is a powerful diagnostic tool but should never be used in isolation for clinical decisions."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Clinical Advisory
This test is intended exclusively for diagnostic and family risk assessment. Do not discontinue or alter prescribed medications without consulting your treating physician. Interpretation of genetic results should always be performed in conjunction with a medical geneticist.
Safety Exclusion & Red Flags
- Exclusion Criteria: Known severe bleeding disorder, anticoagulation therapy with INR >3.0, active skin infection at venipuncture site, inability to provide informed consent.
- Emergency Red Flags Post‑Collection: Fainting, uncontrolled bleeding, signs of infection (redness, swelling, pus). Seek immediate medical attention.
- Pediatric: Parental/guardian consent mandatory per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the COL2A1 Gene Czech Dysplasia NGS test, and who should consider it?
This advanced genetic test precisely identifies COL2A1 gene mutations linked to Czech dysplasia, enabling accurate diagnosis and family planning. The test is recommended for individuals with unexplained short stature, skeletal abnormalities, early‑onset osteoarthritis, or a family history of spondyloepiphyseal dysplasia. Orthopedic surgeons, rheumatologists, and geneticists may refer patients with suspected collagenopathies or atypical bone pain.
2. How is the sample collected, and what preparation is required?
A peripheral whole blood or buccal swab sample is collected in the comfort of your home by our certified phlebotomists using an ISO‑certified cold‑chain kit. No fasting is required. Prior to collection, a genetic counseling session is arranged to document clinical history and construct a pedigree chart of affected family members. Do not discontinue any medication unless advised by your doctor.
3. What do my results mean, and what are the next steps after testing?
A positive result confirms a pathogenic COL2A1 mutation linked to Czech dysplasia, guiding medical management and genetic counseling for relatives. A negative result may exclude the specific variant but does not rule out other genetic etiologies. We recommend a post‑test telephonic consultation with our consultant medical geneticist to explain implications, cascade testing opportunities, and referral to appropriate specialists for longitudinal care.
UAE Regulatory & Data Privacy Adherence
Compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) & Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields
DNA Labs UAE ensures that all genetic data is processed, stored, and transmitted under strict encryption protocols. Patient consent is obtained and documented before any sample collection. Our DHA‑licensed facility (License No. 1143) complies with the highest standards for health information security and patient confidentiality.
Clinical & Logistical Metadata
| Test Name | COL2A1 Gene Czech Dysplasia Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood or buccal swab; VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (available daily 8 AM – 11 PM) |
| Methodology Used | Next‑Generation Sequencing (NGS) with CNV detection |
| ICD-10-CM Code | Q77.7 |
| LOINC Code | 83096-2 |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians